Ecolab Inc. filings document the public-company disclosures of a Delaware operating company whose common stock trades on the New York Stock Exchange under ECL. The filings cover operating and financial results, supplemental segment reporting, changes to reportable segment structure, capital-structure information and material-event reports.
Proxy and 8-K filings describe annual-meeting matters, board and executive-leadership changes, compensation and governance topics, and shareholder voting materials. Other disclosures address material agreements, restructuring and exit-cost matters associated with the One Ecolab initiative, business context for water, hygiene and infection prevention operations, and the company’s service footprint across multiple customer industries.
ECL reports a planned disposition of common stock through Morgan Stanley Smith Barney LLC – Executive Services, with trading on the NYSE referenced for 07/30/2026. The transaction is described as a broker-assisted cashless exercise connected to an employee stock option exercise on the same date.
Disclosed figures in the filing include 3,357, 3,972, and 281,437,502, which relate to the common stock and option activity associated with this planned transaction.
Ecolab Inc. reported strong second‑quarter 2026 results, with net sales of $4,415.4 million, up 10% from $4,025.2 million in 2025, and organic sales growth accelerating to 5%. Reported operating income rose 7% to $757.9 million and adjusted operating income increased 10% to $809.0 million. Reported diluted EPS was $1.90, while adjusted diluted EPS was $2.09, 11% above $1.89 a year earlier.
Performance was broad-based: at fixed currency, Global Water sales grew 10%, Global Institutional & Specialty 4%, Global Pest Elimination 9% and Global Life Sciences 15%, with Life Sciences achieving a 26.5% operating margin. Reported gross margin was 44.1% and organic gross margin 44.9% as stronger pricing and productivity offset higher commodity costs and growth investments. Ecolab Digital sales increased 27% to $121 million. Cash from operating activities for the first half of 2026 was $1,175.4 million, and net debt to adjusted EBITDA was 1.9; the company repurchased about 1.2 million shares in the quarter.
Looking ahead, Ecolab raised its full‑year 2026 adjusted diluted EPS outlook to $8.05–$8.25, implying 7%–10% growth versus last year, and guided third‑quarter adjusted EPS to $2.13–$2.23. Management expects second‑half reported sales to increase 12%–14%, organic sales to grow 6%–7% and adjusted and organic operating income margins of about 19% and 20%, respectively, supported by pricing, acquisitions such as Ovivo Electronics and CoolIT, and continued expansion of its Global High‑Tech and Life Sciences growth engines.
JPMorgan Chase & Co. reports beneficial ownership of 14,448,038 shares of Ecolab Inc. common stock, representing 5.1% of the class.
The firm has sole voting power over 13,045,413 shares and shared voting power over 156,195 shares. It holds sole dispositive power over 14,364,448 shares and shared dispositive power over 82,687 shares, with positions held through multiple JPMorgan subsidiaries.
Ecolab Inc. director John J. Zillmer received a grant of 130.18 shares of Common Stock on June 30, 2026 as a compensation-related award, not an open‑market purchase. This increased his directly held stake to 49,365.43 shares. The total includes 43.39 shares acquired through a dividend reinvestment feature of the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan.
ECOLAB INC. director Julie Whalen reported acquiring 130.18 shares of Common Stock as a stock grant or award at no cash cost. Following this compensation-related acquisition, she holds a total of 471.76 shares directly. This total includes 0.55 shares obtained through a dividend reinvestment feature of the company’s 2001 Non-Employee Director Stock Option and Deferred Compensation Plan.
ECOLAB INC. director Suzanne M. Vautrinot received a grant of 130.18 shares of common stock on June 30, 2026, recorded at no cash price per share. Following this award, her direct holdings total 11,805.02 shares. The total includes 23.62 shares acquired through a dividend reinvestment feature of an Ecolab non-employee director stock and deferred compensation plan.
Ecolab Inc. director Lionel L. Nowell III reported a grant of 130.18 shares of Common Stock. The award was recorded at a price of $0.00 per share, indicating a compensation-related share grant rather than an open-market purchase.
After this transaction, he directly owns 6,773.07 Ecolab shares. The holdings figure includes 17.51 shares acquired through a dividend reinvestment feature of the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan, reflecting ongoing reinvestment of dividends into additional stock.
Ecolab Inc. director Tracy B. McKibben received a grant of 130.18 shares of common stock on June 30, 2026, as a non-cash award. The transaction was recorded at $0.00 per share and increased her directly held position to 11,667.65 shares.
The reported holdings include 21.51 shares acquired through a dividend reinvestment feature of the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan, indicating part of the stake has accumulated automatically over time.
Ecolab Inc. director David MacLennan reported routine equity awards in company stock. On June 30, 2026, he received two acquisitions of common stock totaling 176.19 shares as compensation-related grants, not open-market purchases.
One award covered 46.01 shares at $278.458 per share, and another 130.18-share award was recorded at $0.00 per share. A footnote states that 20.47 of the reported shares were acquired through a dividend reinvestment feature of the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan. Following these transactions, MacLennan holds 25,426.67 shares directly, plus indirect holdings of 709 shares through sibling's trusts and 3,500 shares through the Kathleen F. MacLennan Revocable Trust.
Ecolab Inc. director Michael Larson received a stock grant. On June 30, 2026, he was awarded 130.18 shares of Ecolab common stock as a grant or other acquisition at a stated price of $0.00 per share, indicating compensation rather than an open-market purchase.
After this award, Larson directly owned 19,166.08 shares of Ecolab common stock. This total includes 28.40 shares that were acquired through a dividend reinvestment feature under the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan.